Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World Study
Small-airway disease (SAD) is a key feature of severe asthma and is associated with poor symptom control and frequent exacerbations. Dupilumab has demonstrated efficacy in improving lung function and reducing exacerbations, but real-world evidence on its effects in SAD remains limited. The aim of th...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2026-02-01
|
| Serier: | Advances in Respiratory Medicine |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2543-6031/94/2/14 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
